Xiaoyu Zhi Jiancheng Luo Weiwei Li Jinliang Wang Yuying Wang Yi Cai Xiang Yan
10.3389/fonc.2021.733276
Front Oncol
2021 Oct 25;11:733276.
bevacizumab brain metastasis exon 20 insertion mutation non-small cell lung cancer osimertinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/34760695/
Case Reports
PMC8573166
34760695
Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases
2021